Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/7/2007
 
First Published:
9/1/2001
1.
Phase III Randomized Study of Triacetyluridine and High-Dose Fluorouracil Versus Gemcitabine in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
18 and over
Pharmaceutical / Industry
WELLSTAT-401.00.001
PRONEURON-401.00.001, UAB-0105, UAB-F010524008, NCT00024427
Last Modified:
1/25/2008
 
First Published:
2/1/2000
2.
Phase II Study of Triacetyluridine, Fluorouracil, and Leucovorin Calcium in Patients With Unresectable, Locally Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
18 and over
NCI
SWOG-S9915
NCT00004233, S9915
Last Modified:
6/1/1994
3.
Phase I Study of Triacetyluridine as a Rescue Agent for 5-FU in the Treatment of Patients with Advanced Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Supportive care, Treatment
Closed
18 and over
MSKCC-92074
NCI-V92-0131
Last Modified:
3/1/1995
4.
Phase I Study of Sequential MTX, PALA, and 5-FU with Oral CF and Triacetyluridine Rescue in Patients with Advanced Gastrointestinal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Supportive care, Treatment
Closed
18 and over
NCI
MSKCC-93061A9
NCI-T93-0060D, T93-0060
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute